EndoGastric Solutions secures $50M, Olympus launches endoscopic balloon dilator & more – 3 GI/endoscopy company key notes

Here are three recent news updates on key gastroenterology and endoscopy companies.

PAION initiated a dedicated safety study of Remimazolam in American Society of Anesthesiologists classification III to IV patients undergoing colonoscopy as part of the U.S. Phase III program.

EndoGastric Solutions secured additional financing of up to $50 million.

Olympus launched EZDilate multi-stage endoscopic balloon dilator.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Learning Opportunities

Featured Webinars

Featured Whitepapers

Featured Podcast